- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
                        查看更多
                        
                    
                宫颈癌患者外周血淋巴细胞亚群分布的差异分析
目录
TOC \o 1-9 \h \z \u  目录	 1
  正文	 1
  文1:宫颈癌患者外周血淋巴细胞亚群分布的差异分析	 1
  1 资料与方法	 3
  2 结果	 5
  3 讨论	 7
  文2:中晚期肝癌患者外周血淋巴细胞亚群的研究	 9
  1 材料与方法	 9
  2 结果	 12
  3 讨论	 13
  参考文摘引言:	 14
  原创性声明(模板)	 16
  文章致谢(模板)	 16
正文
宫颈癌患者外周血淋巴细胞亚群分布的差异分析
文1:宫颈癌患者外周血淋巴细胞亚群分布的差异分析
Analysis of the differences of distribution of lymphocyte subsets in peripheral blood in the patients with cervical cancer
YU Hong1 ZHANG Gengyue1 JIN Yulong1 DI Na1 HE Chunying1 WEI Tianxue1 DU Renqiu2
Biology Research Office, Jilin Research Center for Tumor Prevention and Control, Changchun 130012, China;  Record Room, Jilin Tumor Hospital, Changchun 130012, China
[Abstract] Objective To test and analyze the differences of distribution of lymphocyte subsets in peripheral blood in the patients with cervical cancer and its clinical significance. Methods Percentages of CD3+, CD3+CD4+, CD3+CD8+, NK, NKT, CD8+CD28+, CD8+CD28-, CD3+HLA-DR+, CD3-HLA-DR+, Treg cells were tested in adult peripheral blood in the patients with cervical cancer and health controls via flow cytometry. Comparative analysis was conducted in combination with the clinical diagnosis staging in the patients with cervical cancer. Results Compared with the healthy control group, the percentages of CD3+(P=) and CD3+CD4+ T cells(P=) in the peripheral blood in the patients with cervical cancer and CD3+CD4+/CD3+CD8+ ratio(P=) were significantly reduced; the percentages of CD3+CD8+ T cells in the patients with cervical cancer were not statistically significant compared with that in the control group, but with the increase of clinical staging, the percentage was in a decreasing trend(P=). The percentages of NK cells (P), activated T cells (CD3+HLA-DR+:P), and activated B cells (CD3-HLA-DR+: P=) were significantly improved; the percentage of toxic T cells (CD8+CD28+) was reduced (P=), and the percentage of inhibitive T cells(CD8+CD28-) was increased(P=); the percentage of CD4+CD25bright (Treg) cells was not significantly different fr
                 原创力文档
原创力文档 
                        

文档评论(0)